<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Egorova A</submitter><funding>NCATS</funding><funding>NCATS NIH HHS</funding><funding>NIH</funding><pagination>112007</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7002245</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>188</volume><pubmed_abstract>Today, there are no medicines to treat enterovirus and rhinovirus infections. In the present study, a series of novel pleconaril derivatives with substitutions in the isoxazole and phenyl rings was synthesized and evaluated for their antiviral activity against a panel of pleconaril-sensitive and -resistant enteroviruses. Studies of the structure-activity relationship demonstrate the crucial role of the N,N-dimethylcarbamoyl group in the isoxazole ring for antiviral activity against pleconaril-resistant viruses. In addition, one or two substituents in the phenyl ring directly impact on the spectrum of antienteroviral activity. The 3-(3-methyl-4-(3-(3-N,N-dimethylcarbamoyl-isoxazol-5-yl)propoxy)phenyl)-5-trifluoromethyl-1,2,4-oxadiazole 10g was among the compounds exhibiting the strongest ac</pubmed_abstract><journal>European journal of medicinal chemistry</journal><pubmed_title>Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.</pubmed_title><pmcid>PMC7002245</pmcid><funding_grant_id>R21TR001718</funding_grant_id><funding_grant_id>R21 TR001718</funding_grant_id><pubmed_authors>Jahn B</pubmed_authors><pubmed_authors>Ekins S</pubmed_authors><pubmed_authors>Kazakova E</pubmed_authors><pubmed_authors>Makarov V</pubmed_authors><pubmed_authors>Schmidtke M</pubmed_authors><pubmed_authors>Egorova A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.</name><description>Today, there are no medicines to treat enterovirus and rhinovirus infections. In the present study, a series of novel pleconaril derivatives with substitutions in the isoxazole and phenyl rings was synthesized and evaluated for their antiviral activity against a panel of pleconaril-sensitive and -resistant enteroviruses. Studies of the structure-activity relationship demonstrate the crucial role of the N,N-dimethylcarbamoyl group in the isoxazole ring for antiviral activity against pleconaril-resistant viruses. In addition, one or two substituents in the phenyl ring directly impact on the spectrum of antienteroviral activity. The 3-(3-methyl-4-(3-(3-N,N-dimethylcarbamoyl-isoxazol-5-yl)propoxy)phenyl)-5-trifluoromethyl-1,2,4-oxadiazole 10g was among the compounds exhibiting the strongest ac</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Feb</publication><modification>2025-04-19T02:20:41.802Z</modification><creation>2021-02-21T09:33:42Z</creation></dates><accession>S-EPMC7002245</accession><cross_references><pubmed>31881489</pubmed><doi>10.1016/j.ejmech.2019.112007</doi></cross_references></HashMap>